The company said, “Over the past several quarters, the Company has strengthened its Board of Directors, terminated common stock sales under its ATM program, implemented a reduction-in-force, and phased-out its legacy ADVANCE(R) business. As a result, operating expenses and cash usage have been lowered by over $0.5M per quarter. The Company continues to build the Quell Fibromyalgia business via direct-to-physician marketing and sales to Veterans Health Administration facilities. “
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off